Efraim Benmelech

Latest news

Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be

New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.

Bethany McLean’s Weekend Reading List: Elder Care Facilities, Twitter, and Pot

Corruption, lobbying, corporate malfeasance, and frauds: a weekly unconventional selection of must-read articles by investigative journalist Bethany McLean. 

It Is Such a Small World: The Market-Design Academic Community Evolved in a Business Network

Private equity funds such as Michael Dell's MSD Capital made hundreds of millions of dollars in profits from the 2017 FCC spectrum...

How Market Design Economists Helped to Engineer a Mass Privatization of Public Resources

In 2017, the Federal Communications Commission conducted a complex two-sided auction to reallocate spectrum from broadcasters to mobile communications companies. The way...

How Alberto Alesina Challenged the Median Voter Theorem

"Alberto Alesina's insight was that the economy was driven neither by the opportunistic behavior of politicians nor by the pursuit of partisan...

Not Everyone Agreed With Alberto Alesina, but Nobody Could Ignore the Work He Did

Harvard professor Jeffry Fridel was a friend and a colleague of Alberto Alesina. They shared the beginning of their careers, a house...

The Death of Independent Podcasting: What Spotify Is Trying to Do With the Joe Rogan Deal

Spotify is gaining power over podcast distribution by either buying production directly or striking exclusive deals, as it did with Rogan. Once...